The link to this web site does not imply an endorsement of, affiliation or association of any kind with this web site or the third party responsible for it the Company, its affiliates and related companies. In addition, the Company is not responsible for this web site or the information contained or collected therein. Use of this web site is entirely at your own risk and subject to its terms and conditions of use including use of Personal Information. You may not create links from other web sites to this Site without the prior permission of the Company.
由于不了解你女朋友的具体情况,我不好给出意见。从你的另外一个帖子里,我能够感到你对她的关心、你的焦急,但是我也想提醒你,想要关心抑郁症患者的家属,首先要学会关心自己。一个人可以轻易学会不在乎,但学会在乎,却需要付出千百倍的勇气和努力。我的女朋友在陪伴我的时候,自己也经历了不少痛苦。她后来通过咨询心理医生应该怎么照顾我,来调整好了自己的情绪。我想告诉你的是,你要对抑郁症有所准备(教育自己,学习一些这方面的知识),即使你是一个很乐观和活泼的人。陪伴抑郁症患者很消耗人的能量。我给你推荐两个专业团队的回答。https://www.zhihu.com/question/54853415 这个问题中 ID为“简单心理”的回答,这里面你可以读到一些故事(有些故事比较恐怖,你不必被吓到,结合你自己的情况考虑,你女友未必那么严重);Knowyourself这个团队写的http://www.toutiao.com/i6402008917009760769/ “因为爱你,我想陪着你不快乐|研究:抑郁会在伴侣间传染” 。你能来问这个问题,说明你充满了爱心,我为你点赞!祝你女友能走出这段阴霾。
目的观察抑郁大鼠电休克治疗后海马内谷氨酸含量以及N-甲基-D天门冬氨酸(NMDA)受体 的表达,探讨电休克治疗抑郁症的谷氨酸能神经机制。方法36只SD大鼠随机分为无抽搐电休克组(电休克组)、抑郁模型对照组(抑郁组)、对照组,每组12 只。前两组采用孤养加慢性不可预见性应激建立抑郁模型,建模后电休克组在丙泊酚麻醉下行无抽搐电休克治疗,隔天1次共2周。检测各组海马谷氨酸含量和海马 CA1区、CA3区NMDA受体2B亚单位(NMDA-NP,2B)的表达。结果①电休克治疗后电休克组大鼠水平移动格数、垂直竖立次数和糖水消耗量都高 于抑郁组(P〈0.01)。②电休克组大鼠海马内谷氨酸含量低于抑郁组(P〈0.01),而抑郁组高于正常组(P〈0.01)。③电休克组大鼠海马CAI 区和CA3区NMDA.NP,2B的表达量高于正常组(P〈0.05),而抑郁组低于正常组(P〈0.01)。结论无抽搐电休克治疗可抑制抑郁症模型大鼠 海马内谷氨酸含量的升高并使NMDA—NR2B的表达量上调,这可能是其抗抑郁机制之一。
Patients with chronic depression (CD) by definition respond less well to standard forms of psychotherapy, so they are more likely to be high utilizers of psychiatric resources. Therefore, the aim of this guidance paper is to provide a comprehensive overview of current psychotherapy for CD. The evidence of efficacy is critically reviewed and recommendations for clinical applications and research are given. We performed a systematic literature search to identify studies on psychotherapy in CD, evaluated the retrieved documents and developed evidence tables and recommendations through a consensus process among experts and stakeholders. We developed 5 recommendations which may help providers to select psychotherapeutic treatment options for this patient group. The EPA considers both psychotherapy and pharmacotherapy to be effective in CD and recommends both approaches. The best effect is achieved by combined treatment with psychotherapy and pharmacotherapy, which should therefore be the treatment of choice. The EPA recommends psychotherapy with an interpersonal focus (e.g. the Cognitive Behavioural Analysis System of Psychotherapy [CBASP]) for the treatment of CD and a personalized approach based on the patient's preferences. The DSM-5 nomenclature of persistent depressive disorder (PDD), which includes CD subtypes, has been an important step towards a more differentiated treatment and understanding of these complex affective disorders. Apart from dysthymia, ICD-10 still does not provide a separate entity for a chronic course of depression. The differences between patients with acute episodic depression and those with CD need to be considered in the planning of treatment. Specific psychotherapeutic treatment options are recommended for patients with CD. Patients with chronic forms of depression should be offered tailored psychotherapeutic treatments that address their specific needs and deficits. Combination treatment with psychotherapy and pharmacotherapy is the first-line treatment recommended for CD. More research is needed to develop more effective treatments for CD, especially in the longer term, and to identify which patients benefit from which treatment algorithm.
本发明胶囊剂的制作过程为:取熟地1500g,合欢花1500g,柏子仁1500g,香附1500g,柴胡1500g,山药1500g,制首乌1500g,绞股蓝1500g ,栀子1500g,党参1500g,当归1500g,生牡蛎1500g,黄芪1500g,五味子UOOg,淫羊藿1500g,酸枣仁1500g,远志1500g,黄柏15()0g,金线莲l500g,钩藤1500g,力卩10倍量乙醇,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.08(2(TC);上述滤液经体积为IOL的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除乙醇溶剂,得到组份药粉;装入胶嚢制为胶嚢剂,每粒胶嚢装0.3g。可以每12粒为一板。本发明颗粒剂的制作过程为:取熟地2000g,合欢花2000g,柏子仁2000g,香附2000g,柴胡2000g,山药2000g,制首乌2000g,绞股蓝2000g ,梔子2000g,党参2000g,当归2000g,生牡蛎2000g,黄芙2000g,五味子2000g,淫羊藿2000g,酸枣仁2000g,远志2000g g,黄柏20()()g,金线莲2000g,钩藤2000g,将所述组份按配比混合,投入粉碎机粉碎成细粉,细粉过筛后放入耐酸碱浸渍锅内,在常温下,与乙醇共同浸渍20天,将浸渍好的液体及药渣进行压榨过滤,分离后取滤液,加热浓缩至糊状,放入烘箱,控制在8(TC,烘干后冷却,粉碎后加入3000g淀粉混合,制粒、干燥、整粒、分装,包装得成品,每袋4〜6g包装。
抗抑郁药物在治疗患有重度抑郁症或者更严重的成人中有很明显的效果(药物反应率为48%-50%,比安慰剂30-32%高出接近20个百分点)。另外也有部分研究发现结合多种抗抑郁药物,或者在早期增大SSRIs用量的话,疗效可能更好。而对于年龄65岁或者更老的患者,药物疗效的反应率与安慰剂的对比差异就没有那么大了。对于年龄小于13岁的小孩,药物和安慰剂的差异很小,并不显著。抑郁症同样对那些患有生理疾病的抑郁患者有效,但是在患有内科疾病(比如高血压,关节炎,肝炎)的患者中疗效较差。对于安慰剂效应,病情越重的抑郁症和忧郁症中安慰剂效应较小,反之,程度较轻,时间较短并且由之前的生活事件所引发的话抑郁症则安慰剂效应较大。当然,有很多研究争论说药物只在病症严重的患者中才有效果,其实并不是这样,虽然药物在程度严重的患者中效果更好,但是在程度较轻的患者中仍然有明显的医疗效果,而且值得注意的是即使不是精神类药物而是我们日常用的药物,它们的安慰剂与药效的对比其实也是相似的数据,只是我们大众和媒体平时过于关注精神类药物才导致我们觉得精神类药物效果差副作用大(这方面我之前的回答链接里有提到)。
×